Evidence map›Paper›PMID 35077767›Full record

ArticleJournal of molecular biology2022

The Two Non-Visual Arrestins Engage ERK2 Differently.

Nicole A Perry-Hauser, Jesse B Hopkins, Ya Zhuo, Chen Zheng, Ivette Perez, Kathryn M Schultz, Sergey A Vishnivetskiy, Ali I Kaya, Pankaj Sharma, Kevin N Dalby and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Arrestins as Possible Drug Targets.Biomolecules & therapeutics · 2025
    Review
  2. Conformational dynamics of the active state of β-arrestin 1.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. GPCR-dependent and -independent arrestin signaling.Trends in pharmacological sciences · 2024
    Review
  5. Review
  6. Pharmacological reviews · 2023
    Review
  7. Article
  8. Small-angle X-ray scattering studies of enzymes.Current opinion in chemical biology · 2023
    Review
  9. Short Arrestin-3-Derived Peptides Activate JNK3 in Cells.International journal of molecular sciences · 2022
    Article
  10. Review
  11. Solo vs. Chorus: Monomers and Oligomers of Arrestin Proteins.International journal of molecular sciences · 2022
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Nicole A Perry-HauserDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232-0146, United States. Electronic address: https://twitter.com/EmilyBroadis.
Jesse B HopkinsBioCAT, Department of Physics, Illinois Institute of Technology, Chicago, IL 60616, United States.
Ya ZhuoDepartment of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States.
Chen ZhengDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232-0146, United States.
Ivette PerezDepartment of Biochemistry, Vanderbilt University, Nashville, TN 37232-0146, United States; Division of Chemical Biology and Medicinal Chemistry, University of Texas at Austin, Austin, TX 78712, United States.
Kathryn M SchultzDepartment of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States.
Sergey A VishnivetskiyDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232-0146, United States.
Ali I KayaDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232-0146, United States.
Pankaj SharmaDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232-0146, United States.
Kevin N DalbySchool of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro Jangan-gu, Suwon 16419, Republic of Korea.
Ka Young ChungCenter for Structural Biology, Vanderbilt University, Nashville, TN 37232-0146, United States.
Candice S KlugDepartment of Biophysics, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, United States.
Vsevolod V GurevichDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232-0146, United States. Electronic address: vsevolod.gurevich@vanderbilt.edu.
T M IversonDepartment of Pharmacology, Vanderbilt University, Nashville, TN 37232-0146, United States; Department of Biochemistry, Vanderbilt University, Nashville, TN 37232-0146, United States; Division of Chemical Biology and Medicinal Chemistry, University of Texas at Austin, Austin, TX 78712, United States; Vanderbilt Institute for Chemical Biology, Vanderbilt University, Nashville, TN 37232-0146, United States. Electronic address: tina.iverson@vanderbilt.edu.
Vanderbilt University · USMedical College of Wisconsin · USThe University of Texas at Austin · USIllinois Institute of Technology · USSungkyunkwan University · KR

Funding

Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
TR&D Project 3P41EB001980 · NIBIB · MEDICAL COLLEGE OF WISCONSIN · PI KLUG, CANDICE S · 2003 to 2017
$16.3M
STRUCTURE/FUNCTION STUDIES OF VISUAL ARRESTINR01EY011500 · NEI · VANDERBILT UNIVERSITY · PI T M Iverson · 1997 to 2026
$12.3M
Time resolved SAXS studies on the RP2/Arl3 complex pp.484-485P41GM103622 · NIGMS · ILLINOIS INSTITUTE OF TECHNOLOGY · PI IRVING, THOMAS C · 2012 to 2020
$11.9M
MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Regulation of eEF-2K an Energy and Nutrient SensorR01GM123252 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI DALBY, KEVIN N, GHOSE, RANAJEET · 2017 to 2024
$2.7M
Targeted Engineering of Designer Arrestins to Regulate Cell SignalingR35GM122491 · NIGMS · VANDERBILT UNIVERSITY · PI GUREVICH, VSEVOLOD V. · 2017 to 2021
$2.6M
Molecular basis for arrestin-mediated signalingR01GM120569 · NIGMS · VANDERBILT UNIVERSITY · PI T M Iverson · 2016 to 2026
$1.9M
Advanced Pixel Array Detector for Time-Resolved SAXS and Fiber DiffractionS10OD018090 · OD · ILLINOIS INSTITUTE OF TECHNOLOGY · PI IRVING, THOMAS C · 2014 to 2014
$529k
Mechanisms of signal bias in arrestinsR21DA043680 · NIDA · VANDERBILT UNIVERSITY · PI GUREVICH, VSEVOLOD V., IVERSON, T M · 2017 to 2018
$432k
American Heart Association-American Stroke Association 16PRE30180007American Heart Association-American Stroke Association 18PRE34030017NEI NIH HHS P30 EY008126NEI NIH HHS R01 EY011500NIBIB NIH HHS P41 EB001980NIDA NIH HHS R21 DA043680NIGMS NIH HHS P41 GM103622NIGMS NIH HHS R01 GM120569NIGMS NIH HHS R01 GM123252NIGMS NIH HHS R35 GM122491NIGMS NIH HHS T32 GM008320NIH HHS S10 OD018090
6 · The paper itself

Abstract

Arrestin binding to active phosphorylated G protein-coupled receptors terminates G protein coupling and initiates another wave of signaling. Among the effectors that bind directly to receptor-associated arrestins are extracellular signal-regulated kinases 1/2 (ERK1/2), which promote cellular proliferation and survival. Arrestins may also engage ERK1/2 in isolation in a pre- or post-signaling complex that is likely in equilibrium with the full signal initiation complex. Molecular details of these binary complexes remain unknown. Here, we investigate the molecular mechanisms whereby arrestin-2 and arrestin-3 (a.k.a. β-arrestin1 and β-arrestin2, respectively) engage ERK1/2 in pairwise interactions. We find that purified arrestin-3 binds ERK2 more avidly than arrestin-2. A combination of biophysical techniques and peptide array analysis demonstrates that the molecular basis in this difference of binding strength is that the two non-visual arrestins bind ERK2 via different parts of the molecule. We propose a structural model of the ERK2-arrestin-3 complex in solution using size-exclusion chromatography coupled to small angle X-ray scattering (SEC-SAXS). This binary complex exhibits conformational heterogeneity. We speculate that this drives the equilibrium either toward the full signaling complex with receptor-bound arrestin at the membrane or toward full dissociation in the cytoplasm. As ERK1/2 regulates cell migration, proliferation, and survival, understanding complexes that relate to its activation could be exploited to control cell fate.

Indexed as

beta-Arrestin 1beta-Arrestin 2Mitogen-Activated Protein Kinase 1Protein BindingScattering, Small AngleX-Ray Diffractionbeta-Arrestin 1beta-Arrestin 2Mitogen-Activated Protein Kinase 1arrestinextracellular signal-regulated kinase 2protein–protein interactionsprotein scaffoldssmall-angle X-ray scattering

Identifiers

PMID35077767
PMCPMC8977243
OpenAlexW4206931153

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.